Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

Autor: Masi, G. *, Salvatore, L., Boni, L., Loupakis, F., Cremolini, C., Fornaro, L., Schirripa, M., Cupini, S., Barbara, C., Safina, V., Granetto, C., Fea, E., Antonuzzo, L., Boni, C., Allegrini, G., Chiara, S., Amoroso, D., Bonetti, A., Falcone, A.
Zdroj: In Annals of Oncology April 2015 26(4):724-730
Databáze: ScienceDirect